As of 2026-01-02, the Intrinsic Value of Vor Biopharma Inc (VOR) is -805.12 USD. This VOR valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.08 USD, the upside of Vor Biopharma Inc is -6,255.31%.
Based on its market price of 13.08 USD and our intrinsic valuation, Vor Biopharma Inc (VOR) is overvalued by 6,255.31%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -805.12 - -805.12 | -805.12 | -6,255.31% |
| P/E | (2,631.12) - (2,795.36) | (2,689.09) | -20658.8% |
| DDM - Stable | (1,889.72) - (9,114.32) | (5,502.02) | -42164.4% |
| DDM - Multi | (1.51) - (5.42) | (2.33) | -117.8% |
| Market Cap (mil) | 198.98 |
| Beta | 6.46 |
| Outstanding shares (mil) | 15.21 |
| Enterprise Value (mil) | 38.52 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.78% |
| Cost of Debt | 5.00% |
| WACC | 5.72% |